Champions Oncology, Inc. (NASDAQ:CSBR)
| Market Cap | 65.42M-28.4% |
| Revenue (ttm) | 60.66M+6.7% |
| Net Income | -1.14M-138.8% |
| EPS | -0.08-139.4% |
| Shares Out | 13.92M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,843 |
| Open | 4.83 |
| Previous Close | 4.79 |
| Day's Range | 4.70 - 4.83 |
| 52-Week Range | 4.59 - 8.31 |
| Beta | 0.43 |
| Analysts | Buy |
| Price Target | 12.00(+155.32%) |
| Earnings Date | Dec 15, 2026 |
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About CSBR
Champions Oncology, Inc. is dedicated to developing and commercializing cutting-edge technological products and services designed to personalize cancer treatment and streamline the development of oncology drugs across the United States. At the heart of its offerings is the Tumorgraft Technology Platform, an innovative approach that facilitates individualized cancer care by implanting human tumors into immune-deficient mice. Utilizing this proprietary platform, the company not only delivers personalized cancer solutions directly but also provides Translational Oncology Solutions, supporting pharmaceutical and biotechnology companies through their drug development lifecycle. Additionally, Champions Oncology offers Lumin Bioinformatics, a comprehensive software platform and data tool filled with insights from research services and clinical studies, accessible through annual subscriptions. The company distributes its offerings through various channels, including online platforms, word-of-mouth referrals, and a dedicated sales team, reaching both patients and healthcare professionals. Established in 1985, Champions Oncology, Inc. is based in Hackensack, New Jersey, and was formerly known as Champions Biotechnology, Inc. until its name change in April 2011.
$CSBR stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in CSBR holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by CSBR's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
CSBR Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New CSBR patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to CSBR from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in CSBR
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $1.15M |
| VXFVanguard Extended Market ETF | $313.88K |
| IWCiShares Micro-Cap ETF | $130.21K |
| PQSGPGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF | $19.37K |
Estimated from each fund’s disclosed top holdings × AUM
CSBR Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from CSBR’s recent data — informational, not investment advice